202 related articles for article (PubMed ID: 22674901)
21. Cellular prion proteins in humans and cattle but not sheep are characterized by a low-solubility phenotype.
Kuczius T; Groschup MH
Comp Immunol Microbiol Infect Dis; 2013 Dec; 36(6):599-605. PubMed ID: 23948376
[TBL] [Abstract][Full Text] [Related]
22. Prion protein localizes at the ciliary base during neural and cardiovascular development, and its depletion affects α-tubulin post-translational modifications.
Halliez S; Martin-Lannerée S; Passet B; Hernandez-Rapp J; Castille J; Urien C; Chat S; Laude H; Vilotte JL; Mouillet-Richard S; Béringue V
Sci Rep; 2015 Dec; 5():17146. PubMed ID: 26679898
[TBL] [Abstract][Full Text] [Related]
23. PrP(c) mRNA, but not PrP(Sc) is found in the salivary glands of scrapie-infected sheep.
Herrmann LM; Baszler TV; Knowles DP
Biochim Biophys Acta; 2000 Jun; 1479(1-2):147-54. PubMed ID: 11004536
[TBL] [Abstract][Full Text] [Related]
24. Oral Prion Neuroinvasion Occurs Independently of PrP
Marshall A; Bradford BM; Clarke AR; Manson JC; Mabbott NA
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021891
[TBL] [Abstract][Full Text] [Related]
25. Identification of adjacent binding sites for the YY1 and E4BP4 transcription factors in the ovine PrP (Prion) gene promoter.
Burgess ST; Shen C; Ferguson LA; O'Neill GT; Docherty K; Hunter N; Goldmann W
J Biol Chem; 2009 Mar; 284(11):6716-24. PubMed ID: 19129193
[TBL] [Abstract][Full Text] [Related]
26. The transmissible spongiform encephalopathies of livestock.
Greenlee JJ; Greenlee MH
ILAR J; 2015; 56(1):7-25. PubMed ID: 25991695
[TBL] [Abstract][Full Text] [Related]
27. The prion protein in neuroimmune crosstalk.
Salvesen Ø; Tatzelt J; Tranulis MA
Neurochem Int; 2019 Nov; 130():104335. PubMed ID: 30448564
[TBL] [Abstract][Full Text] [Related]
28. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.
Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G
Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583
[TBL] [Abstract][Full Text] [Related]
29. Expression of cellular prion-related protein by murine Langerhans cells and keratinocytes.
Sugaya M; Nakamura K; Watanabe T; Asahina A; Yasaka N; Koyama Yi; Kusubata M; Ushiki Y; Kimura K; Morooka A; Irie S; Yokoyama T; Inoue K; Itohara S; Tamaki K
J Dermatol Sci; 2002 Feb; 28(2):126-34. PubMed ID: 11858951
[TBL] [Abstract][Full Text] [Related]
30. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
31. Prion protein self-interaction in prion disease therapy approaches.
Rigter A; Priem J; Langeveld JP; Bossers A
Vet Q; 2011 Sep; 31(3):115-28. PubMed ID: 22029882
[TBL] [Abstract][Full Text] [Related]
32. The role of PrP in health and disease.
Flechsig E; Weissmann C
Curr Mol Med; 2004 Jun; 4(4):337-53. PubMed ID: 15354865
[TBL] [Abstract][Full Text] [Related]
33. Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein.
Sigurdson CJ; Joshi-Barr S; Bett C; Winson O; Manco G; Schwarz P; Rülicke T; Nilsson KP; Margalith I; Raeber A; Peretz D; Hornemann S; Wüthrich K; Aguzzi A
J Neurosci; 2011 Sep; 31(39):13840-7. PubMed ID: 21957246
[TBL] [Abstract][Full Text] [Related]
34. CNS delivery of vectored prion-specific single-chain antibodies delays disease onset.
Wuertzer CA; Sullivan MA; Qiu X; Federoff HJ
Mol Ther; 2008 Mar; 16(3):481-6. PubMed ID: 18180775
[TBL] [Abstract][Full Text] [Related]
35. Experimental approaches to TSE prevention via inhibition of prion formation.
Politopoulou G
Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
[TBL] [Abstract][Full Text] [Related]
36. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
37. An overview of transmissible spongiform encephalopathies.
Takemura K; Kahdre M; Joseph D; Yousef A; Sreevatsan S
Anim Health Res Rev; 2004 Dec; 5(2):103-24. PubMed ID: 15984319
[TBL] [Abstract][Full Text] [Related]
38. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
39. Prion protein (PrPc) immunocytochemistry and expression of the green fluorescent protein reporter gene under control of the bovine PrP gene promoter in the mouse brain.
Bailly Y; Haeberlé AM; Blanquet-Grossard F; Chasserot-Golaz S; Grant N; Schulze T; Bombarde G; Grassi J; Cesbron JY; Lemaire-Vieille C
J Comp Neurol; 2004 May; 473(2):244-69. PubMed ID: 15101092
[TBL] [Abstract][Full Text] [Related]
40. Selective neuronal targeting in prion disease.
DeArmond SJ; Sánchez H; Yehiely F; Qiu Y; Ninchak-Casey A; Daggett V; Camerino AP; Cayetano J; Rogers M; Groth D; Torchia M; Tremblay P; Scott MR; Cohen FE; Prusiner SB
Neuron; 1997 Dec; 19(6):1337-48. PubMed ID: 9427256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
